Malaria 2014: Advances in Pathophysiology, Biology and Drug Development
Symposium - New York City, United States
With approximately 3.3 billion people (one half of the world’s population) still at risk of contracting malaria, and over 650,000 malaria deaths annually, there is still much work to be done before this disease can be controlled and possibly eradicated. Increased prevention and control measures have led to a 25% worldwide reduction in malaria mortality rates since 2000. However, those living in the poorest countries remain the most vulnerable to malaria, and nearly 90% of all malaria deaths worldwide occur in the sub-Saharan Africa, mostly among children under five years of age infected with the malaria parasite Plasmodium falciparum. This one-day symposium examines the latest developments in understanding disease processes and the biology of the parasite, and developing antimalarial drugs and candidate vaccines. We will present recent research findings including the pathophysiology and neuropathology of cerebral malaria, the molecular mechanisms of sporozoite invasion in the liver, and the development of novel antimalarial therapies. We will also explore drug resistance to the artemisinin derivatives that are the core components of current drug combination therapies. Join us and our outstanding panel of speakers on World Malaria Day for a very exciting symposium.
Organization: New York Academy of Sciences
(Courtesy of Malaria 2014 logo, via malarianexus.com)
Malaria 2014: Advances in Pathophysiology, Biology and Drug Development
Fri, Apr 25, 2014 - Fri, Apr 25, 2014 (8:00am to 5:30pm)
New York Academy of Sciences
250 Greenwich Street, 40th Floor, New York City, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.